Wave Life Sciences Ltd.WVENASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-151.96M
↓ 71% below average
Average (9y)
$-88.79M
Historical baseline
Range
High:$-14.38M
Low:$-192.15M
CAGR
+29.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-151.96M | -639.6% |
| 2023 | $-20.55M | +84.1% |
| 2022 | $-129.14M | -44.2% |
| 2021 | $-89.55M | +23.7% |
| 2020 | $-117.32M | +38.9% |
| 2019 | $-192.15M | -485.8% |
| 2018 | $-32.80M | +68.0% |
| 2017 | $-102.56M | -173.9% |
| 2016 | $-37.44M | -160.3% |
| 2015 | $-14.38M | - |